| Heading: |
Drugs: Expenditure |
| Question ID: |
1811525 |
| UIN: |
59051 |
| House: |
Commons |
| Date tabled: |
2025-06-11 |
| Asking Member ID: |
4495 |
| Asking Member display name: |
Kit Malthouse
|
| Asking Member handle: |
kitmalthouse
|
| Asking Member Twitter reference: |
@kitmalthouse
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, whether his Department plans to align medicines spending growth with NHS budget growth in real terms. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-06-20 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The allowed rate of growth for branded medicines is established by the 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG).The VPAG plays an important role in delivering improved health gains from medicines in the National Health... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |